Company / Tangible Book Value per Share
X4 Pharmaceuticals, Inc Tangible Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.84
FY2025
5-year range
-$6.46 / $6.26
FY2021-FY2025
Trend
+148.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $0.84.
Based on SEC 10-K filings.
0.84 in FY2025 with a 3-year CAGR of -19.7%.
Declined from $1.62 to $0.84 over the past 3 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -19.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share increased 148.6% year-over-year.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.84 | +148.6% |
| FY2024 | $0.34 | -79.2% |
| FY2022 | $1.62 | -74.1% |
| FY2021 | $6.26 | +196.9% |
| FY2020 | -$6.46 | -63.3% |
| FY2018 | -$3.96 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026